Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer
CME Provided by Research to Practice; this symposium is supported by AbbVie Inc., AstraZeneca Pharmaceuticals LP, Clovis Oncology and TESARO. CE is not offered by SGO.
Location: Kalakaua A
Registration Link: www.ResearchToPractice.com/Meetings/GynOnc2019